본문으로
MMadical AI Use
예시병원

A navigator list for people overdue for cancer screening

이 언어의 본문은 아직 없어 영어로 보여 줍니다.

예시 시나리오입니다. 계획을 위한 합성이지, 특정 동료심사 시험 보고가 아닙니다.

This is an illustrative composite, not a trial report. A registry ranks patients who are overdue for a fit test, mammogram, or other screening the health system already recommends. Navigators call down the list. Before anyone trusts the rank order, the team checks whether the score under-calls a language group, a neighborhood, or a payer. No detection-rate improvement is claimed. A biased rank can widen a gap the program meant to close.

임상 현장

A health-system population health team with navigators, working from an existing screening registry rather than from a new disease label.

도구와 공급사

  • Population health registry
  • Outreach workqueue

출처

Illustrative composite, Madical AI Use · 2026년 3월 18일 · 연도 2026

색인 추가일 2026년 3월 18일

출처 열기

태그

  • 인구
  • 형평
  • 선별

교육과 시장 탐색용 항목. 의학 조언도 추천도 아닙니다.

공중보건과 인구

공공 프로그램

A wastewater trend brief for the public health desk

The U.S. CDC National Wastewater Surveillance System publishes pathogen trends from sewage, which health departments read next to emergency and lab data. Some jurisdictions add a statistical nowcast on top of that feed. This card is about the desk workflow, not a claim that a named model forecasts incidence with a stated error. Wastewater is a population signal. It does not diagnose a person.

CDC NWSS · Local epidemiology desk

뉴스 · 2024사례 읽기

영상과 영상의학

규제

Autonomous diabetic retinopathy screening in primary care

IDx-DR, now marketed as LumineticsCore by Digital Diagnostics, was authorized to screen adults with diabetes for more-than-mild diabetic retinopathy without an eye specialist reading the photo first. A primary care team captures images on a specified retinal camera and the software returns a refer-or-rescreen result. It is not a complete eye examination. Pregnancy and several existing retinal conditions sit outside the labeled use.

LumineticsCore (IDx-DR) · Digital Diagnostics · Topcon NW400

뉴스 · 2018사례 읽기

영상과 영상의학

논문

AI-supported reading in the MASAI mammography trial

The MASAI trial in Sweden randomly assigned screening mammograms to AI-supported reading or standard double reading without AI. Transpara scored each exam and routed lower scores to a single reader and the highest score to double reading, with detection marks available on higher-risk exams. This card quotes the prespecified interim safety analysis, not a claim that every screening program should switch.

Transpara 1.7.0 · ScreenPoint Medical

논문 · 2023사례 읽기
후원

이 색인의 임상 독자에게 닿습니다.

후원 안내